Altaweel, L., Chen, Z., Moayeri, M., Cui, X., Li, Y., Su, J., . . . Eichacker, P. Q. (2011). Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.
Chicago-стиль цитированияAltaweel, Laith, et al. Delayed Treatment With W1-mAb, a Chimpanzee-derived Monoclonal Antibody against Protective Antigen, Reduces Mortality From Challenges With Anthrax Edema or Lethal Toxin in Rats and With Anthrax Spores in Mice. 2011.
MLA-цитированиеAltaweel, Laith, et al. Delayed Treatment With W1-mAb, a Chimpanzee-derived Monoclonal Antibody against Protective Antigen, Reduces Mortality From Challenges With Anthrax Edema or Lethal Toxin in Rats and With Anthrax Spores in Mice. 2011.